Avalo Therapeutics (AVTX) Enterprise Value Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.74% |
| Dec 31, 2025 | -1,665.28% |
| Sep 30, 2025 | -71.02% |
| Jun 30, 2025 | -1,618.02% |
| Mar 31, 2025 | -977.35% |
| Dec 31, 2024 | -35.08% |
| Sep 30, 2024 | -4.61% |
| Jun 30, 2024 | -32.20% |
| Mar 31, 2024 | -42.23% |
| Dec 31, 2023 | 70.26% |
| Sep 30, 2023 | 80.36% |
| Jun 30, 2023 | 23.11% |
| Mar 31, 2023 | -4.14% |
| Dec 31, 2022 | 87.48% |
| Sep 30, 2022 | -449.32% |
| Jun 30, 2022 | 88.57% |
| Mar 31, 2022 | 81.63% |
| Dec 31, 2021 | -1,328.38% |
| Sep 30, 2021 | -1,145.30% |
| Jun 30, 2021 | -164.72% |
| Mar 31, 2021 | -147.56% |
| Dec 31, 2020 | 75.57% |
| Sep 30, 2020 | 82.34% |
| Jun 30, 2020 | -35.38% |
| Mar 31, 2020 | -70.10% |
| Dec 31, 2019 | -13.70% |
| Sep 30, 2019 | 77.37% |
| Jun 30, 2019 | 7.55% |
| Mar 31, 2019 | 0.97% |
| Dec 31, 2018 | 90.40% |
| Sep 30, 2018 | 77.63% |
| Jun 30, 2018 | 29.20% |
| Mar 31, 2018 | 33.69% |
| Dec 31, 2017 | 39.46% |
| Sep 30, 2017 | -15.05% |